Navigation Links
Fiberoptic Green System Blade Miller Oxiport

ProductsFiberoptic Green System Blade Miller Oxiport
Company Rusch, Inc.
Item Fiberoptic Green System Blade Miller Oxiport
Features 
  • 5.0mm diameter fiberoptic light pipe
  • No crevices or hard to reach areas
  • Green system fitting to ISO 7376-3 specifications
  • Lifetime warranty; free from manufacturing defects
  • Matte finish
  • Bright, focused light
  • Easy to clean
  • Reduced glare from the blade
  • Interchangeable with other Green systems
  • Description Stainless steel. Lamp is in fiberoptic handle. Green color coding. The blade includes a port that permits delivery of oxygen or other gas mixtures during intubation.
    Info Rusch, Inc.
    Customer Service: (800) 514-7234
    Web site: http://www.rusch.com/

    Related medicine products :

    1. Coaxial Fiberoptic Headlights
    2. Fiberoptic Lightweight Coaxial Rotary Headlight
    3. Neuroview Rigid Body Fiberoptic Neuroendoscopes
    4. Fiberoptic CIS Set
    5. Fiberoptic Light Guide, snap-on
    6. Fiberoptic Light Guide, clip-on
    7. High Transmission Autoclavable Fiberoptic Light Guide, snap-on
    8. High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on
    9. Fiberoptic Light Guide with Fixed ACMI™ Light Source End
    10. Universal Fiberoptic Light Guide (without adapters)
    11. Fiberoptic Green System Laryngoscope Handles
    KOWA Automated Tonometer KT-500
    PCA II Pump
    6060 MULTI-THERAPY Infusion Pump
    AMS Reference Lab
    Medicine Products:
    (Date:11/27/2009)...,Israel,Nov.27/PRNewswire-FirstCall/--ShamirOptica...roviderofinnovativeproductsandtechnologytotheophth...orshaddeclaredadividenddistributioninanaggregateam...edontheNovember25,2009representativerateofexchange...ontheNovember25,2009representativerateofexchange)p...
    (Date:11/27/2009)... Voyant Health™ announced today that Spe... its TraumaCad Enterprise orthopedic templating so... , (PRWEB) November 27, 2...pectrum Health (Grand Rapids, Michigan) has licens...solution and its TraumaCad Extend workflow solutio...
    (Date:11/26/2009)....,Nov.27/PRNewswire/--ThediabetespopulationintheUn...ualmedicalspendingonthediseaseisprojectedtohit$336...blishedintheDecemberissueof DiabetesCare .TheNatio...fNovoNordisk,commissionedtheanalysisbyateamfromthe...thenumberofAmericanslivingwithdiabeteswillrisefrom...
    (Date:11/26/2009)... No more letters from the North Pole, Textsant...essages from Santa , Nort...rational efficiencies at the North Pole Santa Clau...en all over the globe informed of his Christmas pr...;s research department have identified a large and...
    (Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--Whenmostpeoplehearth...orcanalsogivepatientsthehelptheyneed.TMJstandsfort...dible)contacts/connectswithyourskull(temporalbone)...unctionarepainwithchewing,clickingorpoppingoftheja...nincluding:headaches,fatigue,sleepdisturbances,irr...
    Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
    ...e/-- There is a growing popularity amongst,British...olidays. The,decision to travel overseas is increa...us Getaways witnessed an increase in popularity wi...uality (accredited private hospitals) 3. Service ...
    ... Save Lives and Billions of Dollars, GENEVA, SWIT... from more than 150 countries will begin negotiati...mbat illicit trade in tobacco,products - a massive...ments billions in revenue., The Framework Convent...
    ...vine Hires Agency for Public Relations, MISSION V...day announces it now provides public relations sup... in December 2007 on Web site mapping and,messagin...e past year, and we,anticipate many more changes i...
    ...lth care providers play a key role in the likeliho...er. The findings suggest that interventions target...o boost colorectal cancer screening rates, and in ...n the March 15, 2008 issue of CANCER, a peer-revie...
    ... 10, 2008) Unlike the rest of the cells in your b...dates back to the time when mammals began to evolv...irds, have red cells that contain nuclei that are ... blood and boosting our metabolism. , Scientist...
    ...lps guide immune cells to the gut has been newly i... its assault on the body,s immune system, accordin...lergy and Infectious Diseases (NIAID), part of the...ate the complex mechanisms of the pathogenesis of ...
    Other Medicine News:Health News:Surgery Holidays to Malaysia - British Women Tell Their Stories 2Health News:Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 2Health News:Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 3Health News:Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 4Health News:St. Conti Communications to Help Adjust Chiropractor Messaging and Communications 2Health News:Provider influence and patient barriers affect use of colorectal cancer screening 2Health News:How red blood cells nuke their nuclei 2Health News:NIAID scientists identify new cellular receptor for HIV 2
    (Date:11/27/2009)... CHICAGO,Nov.27/PRNewswire/--AttheupcomingRadiolog...ngSunday,RoyalPhilipsElectronics(PHG,AEX:PHI)willd...cssolutionsdesignedtodirectlyaddresstheprioritieso...aginginnovationsthatreflectadesireforvalue,modular...ePhilipstoprovidecontinuedaccesstoadvancedtechnolo...
    (Date:11/25/2009)... LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--Hesk...dvanceddiagnosticandspecialtyproductstotheveterina...sticsCorporationforthesupplyofbloodgasproductsanda...(Logo: http://www.newscom.com/cgi-bin/prnh/2000062...ionforinnovatinginthefieldofadvancedpoint-of-cared...
    (Date:11/25/2009)... CHICAGOandSTAFA,Switzerland,Nov.25/PRNewswire/-- ...nnovativehearingsolutions,presentedthesecondeditio...specialneedsoftheolderpopulation.Theconferencebrou...oundtheworldandmorethan250clinicianswhoworkeveryda...hareexperiencesanddiscussthelatestresearchandtrend...
    Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Healthcare Trust of America Inc Executes Agreement to Acquire a 108 500 SF Medical Office Building Located in Spartanburg South Carolina 61272 1Healthcare Trust of America Inc Executes Agreement to Acquire a 108 500 SF Medical Office Building Located in Spartanburg South Carolina 61272 2Bioniche Pharma Acquires Duraclon 28R 29 28clonidine hydrochloride injection 29 and Methadone Hydrochloride Injection USP 61269 1Bioniche Pharma Acquires Duraclon 28R 29 28clonidine hydrochloride injection 29 and Methadone Hydrochloride Injection USP 61269 2Hollis Eden to Present Interim Data From Its Phase I II Clinical Studies of Apoptone 28R 29 28HE3235 29 at Molecular Targets and Cancer Therapeutics 14819 1Hollis Eden to Present Interim Data From Its Phase I II Clinical Studies of Apoptone 28R 29 28HE3235 29 at Molecular Targets and Cancer Therapeutics 14819 2Hollis Eden to Present Interim Data From Its Phase I II Clinical Studies of Apoptone 28R 29 28HE3235 29 at Molecular Targets and Cancer Therapeutics 14819 3Hollis Eden to Present Interim Data From Its Phase I II Clinical Studies of Apoptone 28R 29 28HE3235 29 at Molecular Targets and Cancer Therapeutics 14819 4Hollis Eden to Present Interim Data From Its Phase I II Clinical Studies of Apoptone 28R 29 28HE3235 29 at Molecular Targets and Cancer Therapeutics 14819 5